In the case of geleophysic dysplasia 2 and Weill-Marchesani syndrome type 2, these fibrillin-1 mutations effect binding regions of LTBPs/TGF-β and share very similar clinical presentations of disease. This evidence concerns the gene TGFB1 and Weill-Marchesani syndrome 2, dominant.